Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2303]

Bringing together the resources of Eastern and Western European institutes

Prof Ioana Neagoe – Institute of Oncology ‘Prof Dr Ion Chiricuta’, Cluj-Napoca...

Bringing together the resources of Eastern and Western European institutes ( Prof Ioana Neagoe – Institute of Oncology ‘Prof Dr Ion Chiricuta’, Cluj-Napoca, Romania )

Recent developments in neoadjuvant therapy

Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany

Recent developments in neoadjuvant therapy ( Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany )

Highlights and goals of IMPAKT 2012

Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium

Highlights and goals of IMPAKT 2012 ( Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium )

PI3K and the heterogeneity of small tumour breast cancer

Dr Sherene Loi – Jules Bordet Institute, Brussels, Belgium

PI3K and the heterogeneity of small tumour breast cancer ( Dr Sherene Loi – Jules Bordet Institute, Brussels, Belgium )

Molecularly characterising triple negative breast cancer

Prof Jorge Reis-Filho – Jules Bordet Institute, Brussels, Belgium

Molecularly characterising triple negative breast cancer ( Prof Jorge Reis-Filho – Jules Bordet Institute, Brussels, Belgium )

Overcoming drug resistance and targeting critical pathways

Dr Larry Norton – Memorial Sloan-Kettering Cancer Center, New York, USA

Overcoming drug resistance and targeting critical pathways ( Dr Larry Norton – Memorial Sloan-Kettering Cancer Center, New York, USA )

Cancer genes differ in different parts of a tumour

Prof Charles Swanton - CRUK London Research Institute and UCL, UK

Cancer genes differ in different parts of a tumour ( Prof Charles Swanton - CRUK London Research Institute and UCL, UK )

Targeting DNA damage response and repair excluding PARP for triple negative...

Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden

Targeting DNA damage response and repair excluding PARP for triple negative breast cancer ( Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden )

Endocrine therapy resistance and next generation sequencing

Prof Matthew Ellis - Washington University, USA

Endocrine therapy resistance and next generation sequencing ( Prof Matthew Ellis - Washington University, USA )

Molecular characterisation of breast cancer: the mutational landscape

Prof Sam Aparicio - University of British Columbia, Vancouver, Canada

Molecular characterisation of breast cancer: the mutational landscape ( Prof Sam Aparicio - University of British Columbia, Vancouver, Canada )

Metabolism in malignant tumors: a new approach for treating breast cancer

Prof Tak Mak - University of Toronto, Canada

Metabolism in malignant tumors: a new approach for treating breast cancer ( Prof Tak Mak - University of Toronto, Canada )

Criteria required before implementation of whole genome arrays in clinical...

Prof Daniel Hays - University of Michigan, Ann Arbor, USA

Criteria required before implementation of whole genome arrays in clinical practice ( Prof Daniel Hays - University of Michigan, Ann Arbor, USA )

More from ecancer